Navigation Links
Pharmaceutical Industry Labor-Management Association Applauds Senator Casey (D-PA) for Biopharmaceutical Job Creation Efforts
Date:12/9/2010

WASHINGTON, Dec. 9, 2010 /PRNewswire-USNewswire/ -- The Pharmaceutical Industry Labor-Management Association (PILMA) today applauded Pennsylvania Senator Robert Casey's record of leadership on the issue of creating high-quality jobs in the life sciences sector.  This afternoon the senator will be joined by Dave Holveck, CEO of Endo Pharmaceuticals, to advance the discussion of promoting innovation in the industry that leads to job growth.

Senator Casey knows first-hand the critical link between public policies that enable the U.S. pharmaceutical industry to remain globally competitive and putting people to work in good-paying, high-quality jobs.  This past fall Senator Casey toured Sheet Metal Workers Local 19 Training Center in Philadelphia, joined by union and company representatives to identify ways of working together to spur jobs and innovation in the industry.  Today he is taking that hands-on experience and translating it to an important discussion about the role that Congress can play in supporting the men and women who make a living in the pharmaceutical industry. 

PILMA recently released an in-depth report on the very subject of today's event, "Jobs Today: Cures Tomorrow—Innovation and the Biopharmaceutical Industry."  In our report, we note that the United States has "the opportunity to create jobs and strengthen U.S. global competitiveness by both promoting and expanding biopharmaceutical industry investment in R&D." 

The ultimate goal, of course is better patient outcomes.  Across the country, working men and women are utilizing the latest innovations to build and maintain facilities, research and find cures to diseases and enhance and sustain the lives of all Americans.

We look forward to working with Senator Casey and members of both parties to advance a pro-innovation, pro-jobs agenda based on creating a business environment that enables the life sciences sector to continue to thrive here in the United States.

For a copy of "Jobs Today: Cures Tomorrow—Innovation and the Biopharmaceutical Industry" or more information about PILMA, log on to www.pilma.org.


'/>"/>
SOURCE Pharmaceutical Industry Labor-Management Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AccuDial® Pharmaceutical Solves OTC Dosing Errors for Childrens Liquid Medications
2. Access Pharmaceuticals Reports Significant Third Party Payer Reimbursement Progress for MuGard
3. Syndax Pharmaceuticals Entinostat Plus Erlotinib Improves Survival in Select NSCLC Patients
4. Lotus Pharmaceuticals Announces Update on Land in Inner Mongolia
5. Reportlinker Adds China Pharmaceutical Market Overview
6. Reportlinker Adds Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions
7. Reportlinker Adds Russia Pharmaceutical Market Overview Pharma Companies Target Russia Despite the Challenges it Presents
8. Reportlinker Adds Global Generic Pharmaceuticals Industry Report
9. Government Regulation of Drug Prices will Increase in Both Mature and Emerging Markets, Including Markets that Traditionally Play a Limited Role in Pharmaceutical Pricing
10. Cipher Pharmaceuticals Using MedAvante Centralized Ratings in Phase 3 Study
11. Data from Phase 2 Study of Alder Biopharmaceuticals Anti-IL-6 Antibody Therapeutic, ALD518, Demonstrate Reversal of Anemia in Patients with Advanced Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 2017 Nevro Corp. (NYSE: NVRO), a global medical ... treatment of chronic pain, today reported financial results for the ... 2016 Accomplishment & Highlights: Achieved ... increase of 228% as reported, over the prior year ... of 612% over the prior year International ...
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Analysis and Strategies - 2016" report to their offering. ... The latest research ... pricing data and benchmarks in the global Oesophageal Cancer market. ... What are the key drugs marketed for Oesophageal Cancer and ...
(Date:2/23/2017)... , Feb. 23, 2017 Regulus ... the discovery and development of innovative medicines targeting microRNAs, ... year 2016 financial results on Thursday, March 2, 2017 ... a conference call and webcast on March 2, 2017 ... and full year 2016 financial results and provide a ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... ... for the National Institute for Health and Care Excellence (NICE) framework. ... the National Health Service (NHS) to search, order and purchase medical and healthcare-related ...
(Date:2/23/2017)... ... February 23, 2017 , ... ERT, a ... today announced that Premier Research, a leading clinical development service provider, has selected ... becoming increasingly complex, due in part to an array of circumstances including the ...
(Date:2/23/2017)... ... (PRWEB) ... opportunity for the nation to come together to combine its ... – with its favorite fruit – apples! To celebrate National ... to join the “Apple Madness” bracket tournament – a five-week, ...
(Date:2/23/2017)... , ... February 23, 2017 , ... HealthPostures, the desk ... an expert sit stand solutions representative to the Minneapolis Home and Garden Show which ... the event that is garnering national attention is the Minneapolis Convention Center. , ...
(Date:2/22/2017)... ... February 22, 2017 , ... Our high-octane society demands higher ... sharpest brain. , Power On, a mental performance enhancer from Modus Nutrition, provides ... Each capsule contains Cognizin® Citicoline, a branded form of the brain health nutrient ...
Breaking Medicine News(10 mins):